Jun 22, 2023, 11:00
Carbiotix AB's ("Carbiotix" or the "Company") preferential issue of units, with a subscription period ending on June 2, 2023, has now been registered at the Swedish Companies Registration Office. The Company hereby announces that the last day of trading in BTU (paid subscribed unit) is 28 June 2023 and the stop day is 30 June 2023. The first day of trading in warrants of series TO 2 is 4 July 2023.
In June 2023, Carbiotix carried out a rights issue which provided the Company with approximately SEK 12 million before issue costs. The rights issue has now been registered at the Swedish Companies Registration Office and the last day of trading in BTU is 28 June 2023 and the cut-off date is 30 June 2023. Shares and warrants of series TO 2 are expected to be distributed to the VP account/depot on 4 July 2023.
After the Swedish Companies Registration Office's registration of the rights issue, the total number of shares in the Company amounts to 20,736,229 and the share capital to SEK 2,073,622.90. In addition, there are 3,190,188 outstanding warrants of series TO 2. The first day of trading in warrants of series TO 2 is 4 July 2023.
In connection with the rights issue, Carbiotix has engaged Sedermera Corporate Finance AB as financial advisor, Markets & Corporate Law Nordic AB as legal advisor and Nordic Issuing AB as issuing agent.
For more information about the rights issue, please contact:
Sedermera Corporate Finance AB
Tel: +46 (0)40 615 14 10
For more information, please contact:
Kristofer Cook, Chairman
Tel: +46 (0)70-879 65 80
Carbiotix AB (CRBX) (www.carbiotix.com) is an award-winning biotechnology company pioneering microbiome health through a portfolio of prebiotic modulators and diagnostic testing services.